Around 20% of very low birthweight infants admitted to a neonatal intensive care unit become hypotensive within 24 hours of their admission. Standard treatment is either expansion of the circulating volume by the infusion of plasma protein fraction or by using dopamine to improve cardiac function. The purpose of this study was to investigate by a randomised controlled trial which was the most appropriate treatment.
A B Gill, A M Weindling Abstract Around 20% of very low birthweight infants admitted to a neonatal intensive care unit become hypotensive within 24 hours of their admission. Standard treatment is either expansion of the circulating volume by the infusion of plasma protein fraction or by using dopamine to improve cardiac function. The purpose of this study was to investigate by a randomised controlled trial which was the most appropriate treatment.
Thirty nine infants were randomised to receive either plasma protein fraction or dopamine as first line treatment if they became hypotensive within 24 hours of admission to the neonatal intensive care unit. Seventeen of 19 (89%) infants responded to dopamine, whereas only 9/20 (45%) responded to plasma protein fraction. The median dose of dopamine needed to increase the blood pressure to at least the 10th centile was 7 5 pLg/kg/min and was infused for a median duration of 18 hours.
These observations suggest that dopamine should be used earlier in the treatment of these infants than has previously been recommended. The implication of these recommendations was that the two major causes of hypotension were hypovolaemia or myocardial dysfunction, or both, probably as a result of perinatal hypoxia and ischaemia. The case for hypovolaemia as the major aetiological factor specifically in hypotensive preterm infants is unproved2 but there is evidence to suggest that myocardial dysfunction plays an important part in infants who become hypotensive in the first 24 hours after birth. 3 In a pilot study we found that infusions of plasma protein fraction as a first line treatment for hypotension were ineffective in 50% of infants. These infants responded to inotropic drugs, but there was often a delay of two to three hours before their blood pressure recovered. This led to the suggestion that the earlier use of an inotropic drug might be more effective than plasma protein fraction in restoring the systemic blood pressure to normal in the first 24 hours after birth. To test this hypothesis we carried out a randomised controlled trial comparing infusions of plasma protein fraction with dopamine as a first line treatment for hypotension after infants had been admitted to the neonatal unit, and after appropriate measures to stabilise them had been carried out on the delivery suite. To our knowledge no previous studies in the VLBW infant have used dopamine before plasma protein fraction specifically for the treatment of hypotension.
Patients and methods

PATIENTS
Infants weighing less than 1501 g at birth and less than 24 hours old who had an indwelling arterial line for the measurement of systemic blood pressure were eligible for the study. If, in the view of the attending doctor, infants were felt to be clinically shocked before the insertion of the arterial line, then 20 ml/kg of plasma protein fraction was given via a peripheral line (resuscitation plasma protein fraction).
Infants who developed hypotension were enrolled into the study. As tPIH=infants born to mothers with pregnancy induced hypertension and whoV treatment for hypertension.
FIo2=fractional inspired oxygen expressed as a percentage; PIP=peak inspiratol pH=arterial pH; a-A ratio=arterial/alveolar oxygen ratio (a marker of the severi membrane disease26). 
Results
Thirty nine VLBW infants developed hypotension in the first 24 hours after birth. Twenty infants received plasma protein fraction and 19 received dopamine as first line treatment. Table 1 shows the del-^.ographic antenatal and clinical data at entry to the trial. There was no statistically significant difference between the two groups in any of the parameters studied. Nine of 20 (45%) infants in the plasma protein fraction group and 10/19 (53%) infants in the dopamine group received resuscitation plasma protein fraction before the insertion of the arterial line (X2=0-45; p=0 52).
Seventeen of 19 (89%) infants responded to dopamine whereas only 9/20 (45%) responded to plasma protein fraction (X2=6-80, p=0 009).
In infants who received dopamine (30/39), as either a first treatment or after plasma protein fraction, the median dose of dopamine required was 7 5 p.g/kg/min and this was infused for a median duration of 18 hours (interquartile range hours). The response to first line treatment was not influenced by treatment of the mother for hypertension or the use of resuscitation plasma protein fraction.
Four of 39 (10%) infants did not respond to either treatment, three in the plasma protein fraction group and one in the dopamine group. Of these, one of the infants in the plasma protein fraction group and the infant in the dopamine group responded to the addition of dobutamine. The remaining two infants in the plasma protein fraction group did not respond to any additional treatment and died within 24 hours of entry. Table 2 shows the long term morbidity and mortality in the two groups. There was no significant difference in the severity of periventricular haemorrhage or the number of infants who died in each group. In those who survived, the duration of positive pressure ventilation and the percentage developing chronic lung disease and retinopathy of prematurity were similar in the two groups. The proportions are based on the number of infants in whom it was possible to make the diagnosis of chronic lung disease and retinopathy of prematurity.
Discussion Survival of VLBW infants has improved in recent years, particularly in those with a birth weight less than 1000 g.7 The use of positive pressure ventilation and more recently the common use of antenatal steroids and intratracheal surfactants have undoubtedly contributed to this, but the incidence of periventricular haemorrhage remains unchanged.8-10 Postnatal care has been focused on maintaining physiological indices, such as blood pressure, within a normal range. " I Many studies have found that hypotension is associated with periventricular haemorrhage.4 [12] [13] [14] [15] [16] In two studies specifically examining its role, Watkins et al4 and Miall-Allen et al'5 showed that infants who had periods of hypotension for more than one hour appeared more likely to develop periventricular haemorrhage than normotensive control infants. Bada et al found that the hypotensive episodes appeared to precede the development of periventricular haemorrhage.16 Direct causation has not been proved, however.
The treatment of hypotension usually includes waiting for a lack of response to plasma protein fraction before prescribing dopamine. The use of this strategy implies that hypovolaemia is considered to be a more important factor than myocardial dysfunction. Although preterm infants with hyaline membrane disease have been shown to be relatively hypovolaemic compared with those without hyaline membrane disease,'7-19 the case for hypovolaemia as the major aetiological factor in hypotension has not been proved. In fact, Barr et al, in a study using radiolabelled albumin, showed that hypotensive infants had similar circulating plasma and blood volumes to normotensive control infants.2 They did not show a significant improvement in the blood pressure after an infusion of plasma protein fraction despite an increase in circulating blood volume. Using two dimensional and Doppler echocardiography, we have shown that cardiac dysfunction is present in nearly 500/o of VLBW infants before they become hypotensive.3
It seems likely that in the first 24 hours after birth the aetiology of hypotension will not always be solely due to either hypovolaemia or myocardial dysfunction, but rather a combination of the two. Intrapartum asphyxia leading to fetal myocardial dysfunction could potentially cause pooling of blood in the placenta and this might result in additional hypovolaemia. Similarly, antepartum haemorrhage, if severe, may not only cause hypovolaemia but is likely to lead to myocardial ischaemia. Treatment of one and not the other is unlikely to increase the infant's blood pressure. Most neonatologists, however, use volume expansion first before giving inotropic drugs. Unfortunately, with present monitoring on most neonatal units it is not possible to determine if infants are purely hypovolaemic, have myocardial dysfunction, or a combination of the two, as the symptoms and signs are similar. Our study showed that dopamine was more effective than plasma protein fraction in raising the blood pressure of VLBW infants who became hypotensive during the first 24 hours after their admission to the neonatal intensive care unit. This does not imply that myocardial dysfunction is the sole cause, but suggests that waiting for a lack of response to plasma protein fraction before using dopamine is inappropriate.
Approximately 50% of all VLBW infants (normotensive and hypotensive) admitted to our neonatal intensive care unit will receive resuscitation plasma protein fraction for the treatment of poor perfusion or metabolic acidosis, or both, before their blood pressure is measured, but only 1 0% of these will become hypotensive and require treatment. The use of resuscitation plasma protein fraction may mean that hypovolaemia was treated in a significant proportion of infants before the blood pressure was measured. This suggests that those infants who subsequently develop hypotension are likely to have myocardial dysfunction or more severe hypovolaemia, or both. The fact that similar numbers of infants in the two groups received 20 ml/kg of resuscitation plasma protein fraction before an invasive measure of blood pressure was available, and that there was no relation with subsequent response to treatment strengthens the argument for the early use of dopamine.
In our study 23 The early use of dopamine did not affect the number of infants developing grade 3 periventricular haemorrhage. As local and systemic factors have been implicated in its aetiology, it was unlikely that a single therapeutic manoeuvre would reduce its incidence. It may be that research needs to focus more on tissue function and the blood pressure needed by an individual subject to optimise it before being able to decide whether a low blood pressure warrants therapeutic intervention. Until proved otherwise, however, it remains the view of most neonatologists that hypotension should be treated. The results of this study suggest that dopamine should be considered at the outset for the treatment of hypotension in VLBW infants. 
